Observational studyFrontiers in immunology2023

Efficacy and safety of Iguratimod as an add-on therapy for refractory lupus nephritis: A preliminary investigational study.

Qingran Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.